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ABSTRACT The vitamin D-induced calcium-binding pro-
tein calbindin-D (CaBP) was localized immunohistochemically
in some but not all of the cell bodies and axons within the
intestinalis nerve of the chicken. Unlike other nerve tissue thus
far examined, the CaBP content of the intestinalis nerve was
decreased in vitamin D deficiency and increased in chicken
adapted to a calcium-deficient diet. These changes are quali-
tatively similar to the pattern of response of enterocytes. The
inclusion of calcium-containing solutions within the duodenal
lumen caused, directly or indirectly, a decrease in the amount
of CaBP in this nerve in a dose-dependent manner. The exact
role of CaBP in intestinalis nerve cells is unknown but may be
in the regulation of intracellular ionic Ca2+ concentrations
during excitation, although other functions of CaBP cannot be
excluded.
The induction of the synthesis of the calcium-binding protein
calbindin-D (CaBP) in intestine, kidney, and certain other
tissues has been shown to be dependent on the seco-steroid
vitamin D or its biologically active metabolites (1, 2). In
severe vitamin D deficiency, the CaBP content of intestinal
mucosa is virtually absent and is considerably decreased in
renal tissue (2). However, brain CaBP does not change in
vitamin D deficiency and remains essentially the same as in
the normal vitamin D-replete animal (3). Based on such
observations, a relationship between the rate of cell turnover
and the rate of decrease of CaBP content with the onset of
vitamin D deficiency in a particular tissue was suggested.
CaBP occurs in two general forms, the avian type of Mr
-28,000 and with four high-affinity calcium-binding sites (Ka,
'-2 x 106 M-1) and the mammalian type of Mr -9,000 and
with two high-affinity binding sites (2). These proteins are
homologous with calmodulin and other members of the
troponin C superfamily of calcium-binding proteins.
The concentration of CaBP in intestinal mucosa is well-
correlated with the transport of calcium across the epithelial
cell barrier and is considered to increase the transfer of
calcium from the microvillar region to the basal-lateral
membrane (4, 5), as well as possibly having other functions
in the transport process (6). CaBP has been localized im-
munohistochemically in certain cells of the brain and central
nervous system, such as the Purkinje cells of the cerebellum,
the hippocampus, and cells of sensory systems (7-15).
Although its function therein is unknown, CaBP may play a
role in the management of intracellular calcium ion concen-
trations. Calcium ions are known to subserve various func-
tions of the nervous system, including the release of neuro-
transmitter, the stimulation of calcium-calmodulin-depen-
dent protein kinases, the operation of calcium-dependent
potassium channels, and, from studies with invertebrates, the
possible involvement in such processes as habituation and
sensitization (16, 17).
Studies reported herein had their origin from the investi-
gation of vitamin D dependency of contractility of smooth
muscle of the vascular system. Preliminary experiments
suggested that the contraction-relaxation cycle of the smooth
muscle present in the caudal mesenteric vein and artery ofthe
chicken, in response to norepinephrine and K+ depolariza-
tion, differed as a function of vitamin D status. Analysis of the
preparation by radioimmunoassay disclosed the presence of
CaBP, subsequently localized in some of the neurons of the
intestinalis nerve, a nerve closely associated with these blood
vessels. Further experimentation showed that CaBP in
intestinalis nerve cells is decreased in vitamin D deficiency
and increased in dietary calcium deficiency, responding
qualitatively the same as CaBP in intestine. These changes in
peripheral nerve were unexpected, based on the prior reports
of the insensitivity of brain CaBP to vitamin D deficiency. It
was also observed that the presence of Ca2l solutions in the
duodenal lumen markedly affected the concentration of
CaBP in the peripheral nerve.
MATERIALS AND METHODS
Tissue (Mesenteric Tissue) for Assay. Blood vessels and
nerves plus immediately adjacent mesentery were dissected
together, starting from the region of the distal intestine in
chickens and progressing in a rostral direction for 4-6 cm.
Specifically, these tissues (here and after referred to as
mesenteric tissue) consisted of the mesothelium and loose
connective tissue of the mesentery, the caudal mesenteric
artery and vein, and closely associated intestinalis nerve
(nerve of Remak). The intestinalis nerve, which is unique to
birds, arises from the central nervous system near the caudal
pole of the kidneys and courses rostralward within the
mesentery.
Immunohistochemical Localization of CaBP. The mesenter-
ic tissue, taken for immunohistochemical analysis, was
removed from 4-week-old White Leghorn chickens, quick
frozen, fixed by freeze substitution for 2 weeks, imbedded,
sectioned and reacted with goat anti-CaBP antiserum, and the
presence of CaBP was determined by the peroxidase-
antiperoxidase technique as described (18). Immunocontrols
underwent reaction with nonimmune goat serum in place of
anti-CaBP.
Radioimmunoassay of CaBP. For the quantification of
CaBP in the mesenteric tissue, the following procedure was
used. The tissue was rinsed in cold 0.9% NaCl solution,
blotted with absorbent paper, minced in 1 ml of ice-cold Tris
buffer mixture (13.7 mM Tris'HCl/0.12 M NaCl/4.7 mM
KCl, pH 7.4), finely dispersed by sonication (Heat Systems/
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Ultrasonics, Plainview, NY), and centrifuged at 30,000 x g
for 1 hr at 40C. The supernate was recovered and analyzed for
CaBP by a radioimmunoassay using 125I-labeled CaBP, es-
sentially as described by McCann et al. (19). Purified stan-
dard CaBP was isolated from chicken duodenum as described
(20).
Electrophoretic Mobility of CaBP from Duodenal and Ner-
vous Tissue. The mesenteric tissue and cerebellar tissue from
4-week-old vitamin D-repleted chicken were prepared as
described above in Tris buffer mixture and centrifuged at
30,000 x g for 30 min. Aliquots of the supernate were
disassociated by incubating at 370C for 30 min in 1%
NaDodSO4/2% 2-mercaptoethanol/0.2% Tris; purified duo-
denal CaBP was similarly treated. These samples, singly or
in combination, were subjected to electrophoresis on
NaDodSO4/polyacrylamide slab gels (21). The resolved pro-
teins were electrophoretically transferred to nitrocellulose
sheets (pore size, 0.45 Am; Millipore), essentially as de-
scribed by Towbin et al. (22). The electrophoretic blots were
incubated in a solution composed of 10% fetal bovine
serum/3% bovine serum albumin in the Tris buffer mixture
for 2 hr at 370C. The membrane was rinsed in Tris-buffered
saline (20 mM Tris-HCI/Q.5 M NaCl, pH 7.5). After incubat-
ing with rabbit anti-chicken CaBP antiserum diluted in
Tris-buffered saline overnight at 20'C-220C, the blot was
thoroughly rinsed. The blot was then incubated for 2 hr at
20'C-220C with horseradish peroxidase (HRP)-conjugated
goat anti-rabbit IgG (Cappel Laboratories, Cochranville, PA)
diluted 1:100 in the Tris buffer mixture containing 10% fetal
bovine serum and 3% bovine serum albumin and was then
thoroughly rinsed again in Tris-buffered saline. For color
development, the Bio-Rad HRP Color Development Kit was
used.
Radial Diffusion Immunoassay for CaBP in Duodenal
Mucosa. CaBP in the mucosa of the duodenum was deter-
mined by a radial immunodiffusion assay as described (3).
Protein Analysis. The protein concentrations of the muco-
sal and mesenteric tissue were determined by the procedure
of Lowry et al. (23), using bovine serum albumin as the
standard protein.
Effect of Vitamin D Deficiency. One-day-old chicks were
fed a rachitogenic diet for 4 weeks. One half of the chicks
were given 500 international units (IU) of vitamin D3 in 0.2 ml
of propylene glycol intramuscularly 72 hr before the exper-
iment. The other half received propylene glycol only. Con-
centrations of CaBP in the duodenal mucosa and the
intestinalis nerve associated with caudal mesentery vessels
were determined as indicated above.
Effect of Adaptation to Calcium-Deficient Diet. One-day-old
chicks were fed a commercial chick starter diet (Agway,
Ithaca, NY) for 3 weeks and subsequently divided into three
groups of five or six chickens per group. The groups were
then fed complete diets that varied only in calcium content
and contained either 0.1%, 1.0%, or 2.0% calcium. Each diet
contained 0.67% phosphorus and 1200 IU of vitamin D3 per
kg of diet. After 8 days on these diets and an overnight fast,
the chickens were killed and the duodenum and mesenteric
tissue were excised for CaBP analysis.
Effect of Intraluminal Calcium and Calcium Absorption.
Vitamin D-repleted chickens were anesthetized with ether
and the duodenum was exposed. Solutions containing NaCl
(150 mM) and 45CaC12 (1 pACi/ml; 1 Ci = 37 GBq) (pH 7.2),
with the total calcium concentration ranging from 1 to 40 mM,
were injected into the duodenal lumen (1 ml per chicken),
using the in situ ligated loop procedure as described (24, 25).
Chickens were anesthetized 15 min later, blood was with-
drawn from the mesenteric vein draining the duodenum, and
45Ca in the venous serum was quantified using a liquid
scintillation counter (Beckman). The mesenteric tissue was
then excised and analyzed for CaBP by radioimmunoassay as
noted above.
RESULTS
Immunohistochemical Localization. After the presence of
immunologically reactive CaBP had been demonstrated in
the mesenteric tissue, the localization of CaBP was deter-
mined immunohistochemically (26). CaBP was not present in
the endothelial cells or in the smooth muscle cells of the
mesenteric vein and artery, but was found in nerve cell bodies
and axons of the intestinalis nerve, a nerve anatomically
associated with these vessels (Fig. 1). It can be seen that only
some of the nerve cells in the ganglion contained CaBP. This
is reminiscent of other nerve tissues-e.g., the brain-in
which only specific neuronal cells were shown to contain
CaBP (7-15). CaBP was also visualized in axons and specif-
ically associated with axonal varicosities.
Radioimmunoassay and Immunoblot. In validating the ra-
dioimmunoassay procedure, it was shown that serial dilu-
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FIG. 1. Localization of CaBP in the intestinalis nerve present in
the mesenteric tissue. (A) Heavy deposits of immunomarker for
CaBP are present over several neuronal cell bodies in the ganglion.
Some cell bodies have immunomarker at a much lower concentration
(arrows), while others have none (open arrowheads). Axons also
contain CaBP within the ganglion but are better visualized outside
the ganglion (C). (B) The immunocontrol is from an adjacent section
reacted with nonimmune serum. (C) Immunomarker for CaBP in
peripheral nerve is present over the axonal varicosities of some
axons. (A and B, x250, bar = 50 ,um; C, x400, bar = 25 Aim.)
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tions of the extract from mesenteric tissue inhibited 1251_
labeled CaBP binding to antibody in parallel to the inhibition
produced by purified CaBP standard solutions (Fig. 2). The
slopes of these two curves were not different, indicating that
the reactive compound in the intestinalis nerve was immu-
nologically identical to CaBP purified from the duodenum.
Furthermore, the immunoblot (Fig. 3) showed that the
immunoreactive proteins in the nerve and cerebellar prepa-
rations have essentially the same electrophoretic mobility as
purified chicken intestinal CaBP. The protein in cerebellum
appears as a doublet, suggesting heterogeneity of CaBP in
this tissue. Previously, Pochet et al. (27) reported the
presence of two CaBPs in rat brain, with apparent molecular
weights of 27,000 and 29,000. A very faint protein band above
the denser band in the intestinalis nerve extract also suggests
the possible presence of two CaBPs in this peripheral nerve.
Effect of Vitamin D Deficiency. The CaBP content of the
intestinalis nerve varied significantly with various treat-
ments, as did duodenal CaBP. As shown in Table 1, the CaBP
content of the duodenal mucosa of the vitamin D-replete
chickens was -40 ,ug per mg of protein, whereas, in the
duodenum of vitamin D-deficient chickens, CaBP could not
be detected by the radial diffusion immunoassay, the absolute
sensitivity ofwhich is <0.3 Ag ofCaBP per mg of protein. The
CaBP in the intestinalis nerve of the vitamin D-supplemented
birds was =480 ng per mg of protein and less in the
unsupplemented chickens by a factor of -2.4, demonstrating
the dependency of CaBP in this nerve on vitamin D status.
Effect of pietary Calcium. Shown in Table 2 are effects of
diets varying in calcium content on the CaBP concentration
of the intestinalis nerve and duodenum. The CaBP concen-
tration in the duodenal mucosa varied indirectly with calcium
intake as expected from earlier observations (25, 28, 29), and
the CaBP associated with the nerve was also significantly less
in those animals consuming the normal (1%) and high (2%)
calcium diets as compared to the animals in the low calcium
(0.1%) group.
Effect of Intraluminal Calcium and Calcium Absorption.
Depicted in Fig. 4 are the changes in the CaBP content of the
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FIG. 2. Effect of unlabeled CaBP and mesenteric tissue extract
on binding (BO) of 1251-labeled CaBP to specific rabbit anti-CaBP
antiserum. Note the parallel decrease in binding by various dilutions
of unlabeled CaBP and the tissue extract. Each point represents the
mean of three determinations. e, CaBP; o, mesenteric tissue extract.
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FIG. 3. Immunoblot of extracts of mesenteric tissue and brain
(cerebellum) and purified CaBP. After NaDodSO4/PAGE, proteins
were electrophoretically transferred to the blots and CaBP was
visualized immunologically (see text). Lanes: A, mesenteric tissue;
B, same as lane A + CaBP; C, CaBP; D, cerebellum + CaBP; E,
cerebellum. The immunoreactive material in each preparation mi-
grated on the NaDodSO4 gels essentially the same as purified CaBP.
A doublet was apparent in the cerebellar extract, which suggests
multiple forms of the brain protein.
intestinalis nerve in response to intraluminal calcium. When
the calcium content of the solution injected into the duodenal
lumen was 10 mM or greater, the CaBP content of the
intestinalis nerve decreased significantly. The absorption of
calcium from the various calcium-containing solutions was
calculated from the specific activity of 45Ca in precursor
compartment (duodenal lumen) and the 45Ca in venous blood,
and these data are also shown in Fig. 4.
DISCUSSION
CaBP, discovered in the intestinal mucosa, has been local-
ized in a number of tissues and organs of chickens, including
the central nervous system and sensory nerves (7-15). Unlike
the intestine, the CaBP content of the brain is not diminished
in the vitamin D-deficient state and remains essentially the
same as in brains of vitamin D-replete chickens (3). However,
Taylor (30) demonstrated an increase in the CaBP concen-
tration in brain tissue when vitamin D was chronically
administered to rachitic chickens. The only other manipula-
tion shown to affect brain CaBP was the production of
epileptic rats by way of the "kindling" procedure, a proce-
dure in which electrical impulses are delivered to the brain at
periodic intervals over a number of days (31); in this situa-
tion, the depletion of CaBP-like immunoreactivity was local-
ized to the dentate granule cell-mossy fiber system of the
hippocampus. Siegel et al. (32) also reported that the direct
injection of pharmacological doses of 1,25-dihydroxyvitamin
Table 1. Effect of vitamin D3 on the CaBP content of the
intestinal mucosa and intestinalis nerve of 4-week-old
rachitic chickens
Mucosal CaBP, Neuronal CaBP,
Treatment Iug per mg of protein ng per mg of protein
Vehicle Undetectable 197 ± 27
Vitamin D3
(500IU)* 40 ± 1 477 ± 47t
Values represent mean ± SEM of five or six chickens per group.
*Administered intramuscularly 72 hr before experiment.
tThe +vitamin D values are significantly greater than -vitamin D
values at P < 0.001.
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Table 2. Effect of dietary calcium on CaBP content of intestinal
mucosa and intestinalis nerve of chickens
Mucosal CaBP, Neuronal CaBP,
Dietary calcium ktg per mg of protein ng per mg of protein
0.1% Ca 34 ± 1* 188 ± 9*
1.0% Ca 13 ± 0.4** 116 ± 11**
2.0% Ca 10 ± 1** 67 ± 6***
Values represent the mean ± SEM of five or six chickens per
group. Dietary calcium contained 0.67% P and 1200 IU of vitamin D3
per kg. Levels of dietary Ca varied as indicated.
*Values designated with different numbers of asterisks in a column
are significantly different at P < 0.001.
D3 into the brain increased the resistance of "kindled" rats
to epileptic-like episodes. This effect of 1,25-dihydroxyvita-
min D3 on seizure activity occurred rapidly (within 5-10 min),
was transient, and is probably too rapid in onset to be
manifested by new protein synthesis. Large doses of vitamin
D were also shown to decrease the number of seizures in
epileptic patients without concomitant changes in serum
calcium and magnesium concentrations (33).
In the present study, it was demonstrated that the concen-
tration of CaBP in the intestinalis nerve associated with the
caudal mesentery vein and artery was significantly lower in
vitamin D-deficient chickens than in the vitamin D-replete
chickens. However, in contrast to the rachitic duodenal
mucosa, which was virtually devoid of CaBP in the severely
vitamin D-deficient chicken, the intestinalis nerve still con-
tained CaBP. The difference in the response of the two
tissues to vitamin D deficiency could be due to differences in
the rate of cell turnover and/or the longevity of the CaBP
mRNA and/or the rate of release of CaBP.
Restriction of the dietary intake of calcium is a known
stimulus for increased production of 1,25-dihydroxyvitamin
D3 by the renal 25-hydroxyvitamin D-la-hydroxylase en-
zyme system (34, 35). As was reported by us (25) and others
(28, 29), the concentration of CaBP in the mucosa varies
indirectly with calcium intake. The data shown herein indi-
cate that CaBP in the intestinalis nerve varies indirectly with
dietary calcium levels-i.e., in the same direction as does the
change in duodenal CaBP concentration. Duodenal CaBP in
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FIG. 4. Effect of the duodenal absorption of calcium on the
concentration of CaBP in the mesenteric tissue. Vitamin D-repleted
chickens were anesthetized and solutions containing various con-
centrations of CaC12 (labeled with 45Ca) were injected into the ligated
duodenal loops (see text). After 15 min, mesenteric venous blood
draining the duodenum and the mesenteric tissue were obtained.
Serum from the venous blood was assayed for 45Ca content and the
depicted 4OCa values were calculated from the quantity of45Ca per ml
of serum divided by the specific activity (45Ca/4OCa) of the injected
solution. CaBP was determined by radioimmunoassay. Note that the
CaBP content of the intestinalis nerve decreased significantly (P <
0.001) when the intraluminal concentration of 'Ca was 10 mM or
greater. *, CaBP; o, serum 4OCa.
the group receiving the 0.1% calcium diet was greater by
=340% when compared to the 2% dietary calcium group and
the increase in nerve CaBP was =280%.
Of interest and indeed unexpected was the response of
CaBP in the intestinalis nerve to a pulse of calcium placed in
the duodenal lumen. The CaBP content of the nerve tissue
decreased substantially 15 min after solutions containing 10
mM or more of calcium were deposited in the duodenal
lumen. The precise stimulus for the decrease of CaBP under
these circumstances is unknown but might be due to a
transient hypercalcemia or, indirectly, the secretion of intes-
tinal hormones, such as cholecystokinin and pentagastrin;
the latter hormones are known affectors of calcitonin release
in some species (36). Perhaps related to these observations is
the report that adrenocorticotropic hormone and insulin (via
the resultant hypoglycemia) caused an increase in CaBP in
plasma of pigs (37), indicating an effect of certain hormones
on the release of CaBP from intracellular sites. Although the
primary source of blood CaBP seems to be the intestinal
mucosa (38, 39), other CaBP-containing tissues, such as
nerve cells, could constitute another source.
The calcium ion plays a significant role in physiological and
biochemical processes in nerve tissue. As is known, calcium is
required for neurotransmitter release and activates, with
calmodulin, such processes as ATP-dependent calcium trans-
port, phosphorylation ofneuronal proteins, glycogenolysis, and
neurotransmitter synthesis. The calcium that participates in
such reactions could be derived from extracellular sources,
entering neuronal tissue through potential and/or receptor-
operated calcium channels, or from internal stores. The pres-
ence of CaBP in specific neurons might exert important effects
on the control of neuronal function through its ability to bind
calcium with high affinity and thereby control intracellular Ca2+
levels by essentially serving as a calcium buffer, as suggested by
Baimbridge et al. (40). The resting free Ca2' concentration in
most cells is considered to be 10-7 M and CaBP, with a
dissociation constant of -0.5 x 10-7 M, could influence
intracellular free Ca2' levels in this capacity. The buffer
function of CaBP could place a constraint on the excessive
increase in intracellular Ca2+ upon agonist stimulation or
depolarization, or it could maintain intracellular Ca2' levels at
stimulatory concentrations over a longer period of time than in
its absence. It is also possible that neuronal CaBP has other
functions since there is evidence that the Mr 28,000 CaBP from
chicken intestine and the Mr 9000 CaBP from bovine intestine
can stimulate the activity of the intestinal basolateral ATP-
dependent calcium pump (6, 41, 43).
The physiological and pathological implications of the
dependency of CaBP in the intestinalis nerve on calcium and
vitamin D status cannot be defined from current data.
However, a relationship between calcium, vitamin D intake,
and hypertension in certain individuals has been reported
(42). The possibility exists that CaBP in peripheral nerve
might modulate smooth muscle contractility, thereby deter-
mining the degree of vascular resistance and, as a conse-
quence, regional blood flow and blood pressure. It would be
of interest, therefore, to determine whether CaBP is present
in peripheral nerves of humans and, if so, its dependency on
vitamin D and calcium status.
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